Archive for January, 2010

Elan Drug Technologies, a business unit of Elan Corporation, plc (NYSE: ELN) today issued the following statement regarding the U.S. Food and Drug Administration (FDA) approval of AMPYRA™ (dalfampridine) as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. AMPYRA™ will be marketed in the U.S…

Biogen Idec (NASDAQ: BIIB) today issued the following statement regarding the United States (U.S.) Food and Drug Administration (FDA) approval of AMPYRA™ (dalfampridine) to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. The U.S. FDA approval was granted on January 22, 2010. AMPYRA will be marketed in the U…

Title: FDA Warns of Heart Risks With Diet Drug
Category: Health News
Created: 1/21/2010 2:10:00 PM
Last Editorial Review: 1/22/2010

The Food and Drug Administration has approved the drug fampridine-SR for the treatment of multiple sclerosis…

Used to treat pneumonia, throat infections, tonsillitis, bronchitis, middle ear infections, Typhoid and sinusitis, azithromycin is truly one of the world’s best known antibiotics for treating bacterial infections. It can also be used to treat and control Lyme disease, late-onset asthma and malaria, when combined with other important drugs. The antibiotic can be given orally through tablets or liquid and also intravenously. Unlike many drugs, azithromycin can usually be taken on an empty stomach, as this helps its effectiveness and absorption. Used by various names depending on the country, a Azithromycin supplier is generally pretty easy to find, as this drug is well accepted, effective and easy to use.

The U.S. Food and Drug Administration approved Ampyra (dalfampridine) extended release tablets to improve walking in patients with multiple sclerosis (MS). In clinical trials, patients treated with Ampyra had faster walking speeds than those treated with an inactive pill (placebo). This is the first drug approved for this use…

EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany, announced the online publication of the results from the CLARITY(1) Phase III trial using Cladribine Tablets (EMD Serono’s proprietary investigational oral formulation of cladribine) in The New England Journal of Medicine(2)…

For many of us who go through stressful days of activities, we need every minute of deep sleep that we can get. Those with medical conditions requiring prolonged bed rest can also benefit from resting on an adjustable comfortable bed. An electric massage bed can offer you these benefits. Massage therapy is a technique used by many people for years to alleviate stress and pain. Beds these days now feature this capability, allowing you to achieve deep levels of relaxation you deserved after a full-day’s work. Your blood circulation could also be improved through massage. Massage chairs and tables can also help bring down the pains brought about by arthritis.

Title: New Gene ID’d in Brittle Bone Disease
Category: Health News
Created: 1/20/2010 4:10:00 PM
Last Editorial Review: 1/21/2010

The European Medicines Agency has finalised a review of Tysabri (natalizumab) and the risk of progressive multifocal leukoencephalopathy (PML), a rare brain infection caused by the JC virus. The Agency’s Committee for Medicinal Products for Human Use (CHMP) has concluded that the risk of developing PML increases after two years of use of Tysabri although this risk remains low…